BTAI Archived Articles
BioXcel Therapeutics, Inc. (BTAI): A Pioneering Biopharmaceutical Company Leveraging AI to Develop Transformative Medicines
Published on November 05, 2024
BioXcel Therapeutics, Inc. (NASDAQ:BTAI): Advancing Neuroscience and Immuno-Oncology Pipelines, Driving IGALMI Commercialization
Published on September 24, 2024